Prepare for your visit
Colin T Iosso
Neurology (Psychiatry & Neurology) · Tacoma, WA · NPI 1538137484
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$965.79
in general payments reported to CMS, 2019-2025 · $379 in 2025
The $379 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Eisai INC. $243.96
- Teva Pharmaceuticals USA, INC. $209.58
- Edwards Lifesciences Corporation $134.81
- Alexion Pharmaceuticals, INC. $133.80
- Amgen INC. $125.00
- Stemline Therapeutics INC. $103.02
Drugs and devices associated with these payments
Leqembi Edwards Sapien 3 Transcatheter Heart Valve (Thv) Orserdu Ultomiris
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Colin Iosso listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/24350/colin-t-iosso